IO BIOTECH INC (IOBT) Stock Income Statement
NASDAQ:IOBT - Nasdaq - US4497781090 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 96.42M | 91.44M | 71.42M | 41.23M | 10.15M | |||
| Research and Development | 72.11M | 67.83M | 46.99M | 30.15M | 8.46M | |||
| Selling, General, and Administrative Expenses | 24.31M | 23.61M | 24.44M | 11.08M | 1.68M | |||
| Operating Income | -96.42M | -91.44M | -71.42M | -41.23M | -10.15M | |||
| Interest Income/Expense | 7.43M | 6.21M | 1.24M | -40.00K | -1.90M | |||
| Other Income/Expense | N/A | N/A | 0.00 | -26.54M | N/A | |||
| Income Before Taxes | -88.99M | -85.23M | -70.19M | -67.81M | -12.04M | |||
| Income Tax | 1.35M | 852.00K | 1.27M | 70.00K | 0.00 | |||
| Net Income | -90.34M | -86.08M | -71.46M | -74.99M | -14.59M | |||
| EBITDA | -96.17M | -91.23M | -71.32M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.37 | -1.98 | -2.48 | -2.60 | -0.53 | |||
| Non GAAP EPS | -1.37 | -2.16 | -2.50 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD